Douglas Muir
Latest contributions
Featured research - Aortic valve (Part 11)
26 Nov 2024 – From PCR London Valves 2024
Explore the latest advancements in aortic valve research during this featured session, showcasing selected abstracts from the upcoming PCR London Valves 2024 conference. Delve into topics ranging from the long-term outcomes of bailout valve-in-valve TAVI, the performance of the Navitor THV in bicuspid aortic valves, novel...
Featured cases - TAVI in unusual anatomical situations
26 Nov 2024 – From PCR London Valves 2024
Delve into a collection of TAVI cases in unusual anatomical situations, offering valuable insights for navigating complex scenarios. Discover successful percutaneous approaches to address conditions like bicuspid valves with membranous interventricular septum aneurysm, subaortic membrane, and pure aortic regurgitation in quadricuspid valves. Explore strategies for managing...
Featured cases - TAVI coronary protection strategies (Part 2)
25 Nov 2024 – From PCR London Valves 2024
Delve into this captivating session showcasing a collection of complex TAVI cases from PCR London Valves 2024, with a focus on coronary protection strategies. Explore innovative approaches to managing complications such as acute left main occlusion, degenerated sutureless bioprosthesis, and the Basilica-Unicorn technique. Gain invaluable insights...
TAVI pathway optimisation in Europe, insights and evidence
29 Nov 2023 – From PCR London Valves 2023
In this roundtable, Francesco Saia, Derk Frank and Douglas Muir discuss the need for TAVI pathway optimisation and Edwards' clinical project called Benchmark program, which comprises the best practices based on the evidence regarding pre- peri-and post-procedural TAVI phases.
This interview was filmed at PCR London Valves...
Improving patient access and clinical outcomes in the treatment of aortic stenosis - The Edwards Benchmark Program
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the current and future constraints on aortic stenosis treatment in Europe, and gain insight into the Edwards Benchmark Program, aiming to optimize patient outcomes, care pathway and efficiency.
